{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T18:33:14Z","timestamp":1783103594562,"version":"3.54.6"},"reference-count":99,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.leukres.2024.107566","type":"journal-article","created":{"date-parts":[[2024,8,25]],"date-time":"2024-08-25T13:54:10Z","timestamp":1724594050000},"page":"107566","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Germline genetic variants that predispose to myeloproliferative neoplasms and hereditary myeloproliferative phenotypes"],"prefix":"10.1016","volume":"146","author":[{"given":"Jonathan","family":"Lim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Ross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna L.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamish S.","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher N.","family":"Hahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2024.107566_bib1","doi-asserted-by":"crossref","first-page":"771","DOI":"10.3904\/kjim.2015.30.6.771","article-title":"Guidelines for the management of myeloproliferative neoplasms","volume":"30","author":"Choi","year":"2015","journal-title":"Korean J. Intern. Med."},{"key":"10.1016\/j.leukres.2024.107566_bib2","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1182\/blood-2008-03-143602","article-title":"Increased risks of polycythemia vera, essential thrombocythemia, and myelofibrosis among 24,577 first-degree relatives of 11,039 patients with myeloproliferative neoplasms in Sweden.","volume":"112","author":"Landgren","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2024.107566_bib3","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1182\/blood-2018-06-858597","article-title":"Familial risks of acute myeloid leukemia, myelodysplastic syndromes, and myeloproliferative neoplasms","volume":"132","author":"Sud","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2024.107566_bib4","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s10549-017-4325-2","article-title":"Family history and risk of breast cancer: an analysis accounting for family structure","volume":"165","author":"Brewer","year":"2017","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.leukres.2024.107566_bib5","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1111\/j.1572-0241.2001.04677.x","article-title":"A systematic review and meta-analysis of familial colorectal cancer risk","volume":"96","author":"Johns","year":"2001","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.leukres.2024.107566_bib6","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1182\/blood.2019001362","article-title":"Analysis of 153 115 patients with hematological malignancies refines the spectrum of familial risk","volume":"134","author":"Sud","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2024.107566_bib7","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1038\/ng.3380","article-title":"Germline duplication of ATG2B and GSKIP predisposes to familial myeloid malignancies","volume":"47","author":"Saliba","year":"2015","journal-title":"Nat. Genet."},{"key":"10.1016\/j.leukres.2024.107566_bib8","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1182\/blood-2015-09-668673","article-title":"Germline RBBP6 mutations in familial myeloproliferative neoplasms","volume":"127","author":"Harutyunyan","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2024.107566_bib9","doi-asserted-by":"crossref","first-page":"923","DOI":"10.7314\/APJCP.2016.17.3.923","article-title":"Coexisting JAK2V617F and CALR Exon 9 Mutations in Myeloproliferative Neoplasms - Do They Designate a New Subtype?","volume":"17","author":"Ahmed","year":"2016","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"10.1016\/j.leukres.2024.107566_bib10","doi-asserted-by":"crossref","first-page":"57036","DOI":"10.18632\/oncotarget.10958","article-title":"Coexistence of JAK2 and CALR mutations and their clinical implications in patients with essential thrombocythemia","volume":"7","author":"Kang","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.leukres.2024.107566_bib11","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232012582","article-title":"The Contribution of JAK2 46\/1 Haplotype in the Predisposition to Myeloproliferative Neoplasms","volume":"23","author":"Paes","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.leukres.2024.107566_bib12","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/ng.334","article-title":"JAK2 haplotype is a major risk factor for the development of myeloproliferative neoplasms","volume":"41","author":"Jones","year":"2009","journal-title":"Nat. Genet."},{"key":"10.1016\/j.leukres.2024.107566_bib13","doi-asserted-by":"crossref","DOI":"10.1038\/ng.341","article-title":"A common JAK2 haplotype confers susceptibility to myeloproliferative neoplasms","volume":"41","author":"Olcaydu","year":"2009","journal-title":"Nat. Genet."},{"key":"10.1016\/j.leukres.2024.107566_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19041152","article-title":"The JAK2 GGCC (46\/1) Haplotype in Myeloproliferative Neoplasms: Causal or Random?","volume":"19","author":"Anelli","year":"2018","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.leukres.2024.107566_bib15","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1038\/leu.2009.110","article-title":"The 'GGCC' haplotype of JAK2 confers susceptibility to JAK2 exon 12 mutation-positive polycythemia vera","volume":"23","author":"Olcaydu","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2024.107566_bib16","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1038\/leu.2013.21","article-title":"JAK2V617F allele burden, JAK2 46\/1 haplotype and clinical features of Chinese with myeloproliferative neoplasms","volume":"27","author":"Wang","year":"2013","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2024.107566_bib17","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/ng.342","article-title":"A germline JAK2 SNP is associated with predisposition to the development of JAK2(V617F)-positive myeloproliferative neoplasms.","volume":"41","author":"Kilpivaara","year":"2009","journal-title":"Nat. Genet."},{"key":"10.1016\/j.leukres.2024.107566_bib18","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s13353-012-0125-x","article-title":"The influence of novel transcriptional regulatory element in intron 14 on the expression of Janus kinase 2 gene in myeloproliferative neoplasms","volume":"54","author":"Spasovski","year":"2013","journal-title":"J. Appl. Genet."},{"key":"10.1016\/j.leukres.2024.107566_bib19","doi-asserted-by":"crossref","first-page":"4517","DOI":"10.1182\/blood-2009-08-236448","article-title":"The JAK2 46\/1 haplotype predisposes to MPL-mutated myeloproliferative neoplasms","volume":"115","author":"Jones","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2024.107566_bib20","doi-asserted-by":"crossref","first-page":"6691","DOI":"10.1038\/ncomms7691","article-title":"Genetic variation at MECOM, TERT, JAK2 and HBS1L-MYB predisposes to myeloproliferative neoplasms","volume":"6","author":"Tapper","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.leukres.2024.107566_bib21","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1007\/s00277-014-2134-9","article-title":"The JAK2 46\/1 haplotype (GGCC) in myeloproliferative neoplasms and splanchnic vein thrombosis: a pooled analysis of 26 observational studies","volume":"93","author":"Li","year":"2014","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.leukres.2024.107566_bib22","doi-asserted-by":"crossref","first-page":"e86","DOI":"10.1016\/j.thromres.2013.06.021","article-title":"The association of the JAK2 46\/1 haplotype with non-splanchnic venous thrombosis","volume":"132","author":"Zerjavic","year":"2013","journal-title":"Thromb. Res."},{"key":"10.1016\/j.leukres.2024.107566_bib23","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.mrfmmm.2010.01.017","article-title":"Genetic factors in chronic inflammation: single nucleotide polymorphisms in the STAT-JAK pathway, susceptibility to DNA damage and Crohn's disease in a New Zealand population","volume":"690","author":"Ferguson","year":"2010","journal-title":"Mutat. Res."},{"key":"10.1016\/j.leukres.2024.107566_bib24","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1080\/10428194.2016.1198956","article-title":"Recipient and donor JAK2 46\/1 haplotypes are associated with acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation","volume":"58","author":"Balassa","year":"2017","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.leukres.2024.107566_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2020.100710","article-title":"Germline genetic factors in the pathogenesis of myeloproliferative neoplasms","volume":"42","author":"Bellanne-Chantelot","year":"2020","journal-title":"Blood Rev."},{"key":"10.1016\/j.leukres.2024.107566_bib26","doi-asserted-by":"crossref","first-page":"5284","DOI":"10.1038\/s41467-022-32986-7","article-title":"Germline-somatic JAK2 interactions are associated with clonal expansion in myelofibrosis","volume":"13","author":"Brown","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.leukres.2024.107566_bib27","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.cancergen.2011.11.002","article-title":"The genetics of dyskeratosis congenita","volume":"204","author":"Mason","year":"2011","journal-title":"Cancer Genet."},{"key":"10.1016\/j.leukres.2024.107566_bib28","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1038\/leu.2014.48","article-title":"The germline sequence variant rs2736100_C in TERT associates with myeloproliferative neoplasms","volume":"28","author":"Oddsson","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2024.107566_bib29","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.exphem.2013.03.007","article-title":"Telomere shortening in Ph-negative chronic myeloproliferative neoplasms: a biological marker of polycythemia vera and myelofibrosis, regardless of hydroxycarbamide therapy","volume":"41","author":"Ruella","year":"2013","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.leukres.2024.107566_bib30","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/leu.2008.319","article-title":"Telomere length is severely and similarly reduced in JAK2V617F-positive and -negative myeloproliferative neoplasms","volume":"23","author":"Bernard","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2024.107566_bib31","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/s41408-020-00356-5","article-title":"Genetic polymorphisms associated with telomere length and risk of developing myeloproliferative neoplasms","volume":"10","author":"Giaccherini","year":"2020","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.leukres.2024.107566_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.589929","article-title":"TERT-Regulation and Roles in Cancer Formation","volume":"11","author":"Dratwa","year":"2020","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.leukres.2024.107566_bib33","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1182\/blood-2015-06-652941","article-title":"Germ line variants predispose to both JAK2 V617F clonal hematopoiesis and myeloproliferative neoplasms","volume":"128","author":"Hinds","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2024.107566_bib34","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1038\/s41588-022-01121-z","article-title":"Genome-wide analyses of 200,453 individuals yield new insights into the causes and consequences of clonal hematopoiesis","volume":"54","author":"Kar","year":"2022","journal-title":"Nat. Genet."},{"key":"10.1016\/j.leukres.2024.107566_bib35","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/ng.531","article-title":"Genome-wide association study of hematological and biochemical traits in a Japanese population","volume":"42","author":"Kamatani","year":"2010","journal-title":"Nat. Genet."},{"key":"10.1016\/j.leukres.2024.107566_bib36","doi-asserted-by":"crossref","first-page":"76204","DOI":"10.18632\/oncotarget.19211","article-title":"Germline variations at JAK2, TERT, HBS1L-MYB and MECOM and the risk of myeloproliferative neoplasms in Taiwanese population","volume":"8","author":"Chiang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.leukres.2024.107566_bib37","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/ajh.24946","article-title":"MECOM, HBS1L-MYB, THRB-RARB, JAK2, and TERT polymorphisms defining the genetic predisposition to myeloproliferative neoplasms: A study on 939 patients","volume":"93","author":"Trifa","year":"2018","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.leukres.2024.107566_bib38","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1007\/s00277-016-2787-7","article-title":"TERT rs2736100 genotypes are associated with differential risk of myeloproliferative neoplasms in Swedish and Chinese male patient populations","volume":"95","author":"Dahlstrom","year":"2016","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.leukres.2024.107566_bib39","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1182\/bloodadvances.2018016501","article-title":"MECOM-associated syndrome: a heterogeneous inherited bone marrow failure syndrome with amegakaryocytic thrombocytopenia","volume":"2","author":"Germeshausen","year":"2018","journal-title":"Blood Adv."},{"key":"10.1016\/j.leukres.2024.107566_bib40","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2024.107566_bib41","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1038\/leu.2017.139","article-title":"The role of LNK\/SH2B3 genetic alterations in myeloproliferative neoplasms and other hematological disorders","volume":"31","author":"Maslah","year":"2017","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2024.107566_bib42","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/ajh.24259","article-title":"LNK mutations and myeloproliferative disorders","volume":"91","author":"McMullin","year":"2016","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.leukres.2024.107566_bib43","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/s41586-020-2786-7","article-title":"Inherited myeloproliferative neoplasm risk affects haematopoietic stem cells","volume":"586","author":"Bao","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.leukres.2024.107566_bib44","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.cell.2023.12.016","article-title":"Inherited blood cancer predisposition through altered transcription elongation","volume":"187","author":"Zhao","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.leukres.2024.107566_bib45","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.cell.2020.08.008","article-title":"The Polygenic and Monogenic Basis of Blood Traits and Diseases","volume":"182","author":"Vuckovic","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.leukres.2024.107566_bib46","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/s41588-023-01638-x","article-title":"Inherited polygenic effects on common hematological traits influence clonal selection on JAK2(V617F) and the development of myeloproliferative neoplasms.","volume":"56","author":"Guo","year":"2024","journal-title":"Nat. Genet."},{"key":"10.1016\/j.leukres.2024.107566_bib47","article-title":"Recurrent germline variant in ATM associated with familial myeloproliferative neoplasms","author":"Braunstein","year":"2022","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2024.107566_bib48","doi-asserted-by":"crossref","DOI":"10.3324\/haematol.2024.285539","article-title":"Evaluation of the ATM L2307F germline variant in 121 Italian pedigrees with familial myeloproliferative neoplasms","author":"Borsani","year":"2024","journal-title":"Haematologica"},{"key":"10.1016\/j.leukres.2024.107566_bib49","doi-asserted-by":"crossref","first-page":"3373","DOI":"10.1182\/bloodadvances.2021004811","article-title":"Germline variants in DNA repair genes, including BRCA1\/2, may cause familial myeloproliferative neoplasms","volume":"5","author":"Elbracht","year":"2021","journal-title":"Blood Adv."},{"key":"10.1016\/j.leukres.2024.107566_bib50","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1007\/s00277-021-04562-4","article-title":"Novel germline mutation KMT2A G3131S confers genetic susceptibility to familial myeloproliferative neoplasms","volume":"100","author":"Yin","year":"2021","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.leukres.2024.107566_bib51","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/s41419-022-05035-w","article-title":"CHST15 gene germline mutation is associated with the development of familial myeloproliferative neoplasms and higher transformation risk","volume":"13","author":"Chen","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.leukres.2024.107566_bib52","article-title":"Current Understanding of DDX41 Mutations in Myeloid Neoplasms","volume":"15","author":"Kim","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.leukres.2024.107566_bib53","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1182\/blood.2023020209","article-title":"Prevalence and significance of DDX41 gene variants in the general population","volume":"142","author":"Cheloor Kovilakam","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2024.107566_bib54","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1182\/blood.2022018221","article-title":"Germ line DDX41 mutations define a unique subtype of myeloid neoplasms","volume":"141","author":"Makishima","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2024.107566_bib55","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1182\/blood.2021015135","article-title":"The genetic landscape of germline DDX41 variants predisposing to myeloid neoplasms","volume":"140","author":"Li","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2024.107566_bib56","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1002\/ajh.25486","article-title":"DDX41 mutations in myeloid neoplasms are associated with male gender, TP53 mutations and high-risk disease","volume":"94","author":"Quesada","year":"2019","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.leukres.2024.107566_bib57","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1111\/bjh.16668","article-title":"Molecular and clinical features of myeloid neoplasms with somatic DDX41 mutations","volume":"192","author":"Qu","year":"2021","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.leukres.2024.107566_bib58","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/13793","article-title":"Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia","volume":"23","author":"Song","year":"1999","journal-title":"Nat. Genet."},{"key":"10.1016\/j.leukres.2024.107566_bib59","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1182\/bloodadvances.2019000901","article-title":"RUNX1-mutated families show phenotype heterogeneity and a somatic mutation profile unique to germline predisposed AML","volume":"4","author":"Brown","year":"2020","journal-title":"Blood Adv."},{"key":"10.1016\/j.leukres.2024.107566_bib60","doi-asserted-by":"crossref","first-page":"3004","DOI":"10.3324\/haematol.2021.278762","article-title":"The RUNX1 database (RUNX1db): establishment of an expert curated RUNX1 registry and genomics database as a public resource for familial platelet disorder with myeloid malignancy","volume":"106","author":"Homan","year":"2021","journal-title":"Haematologica"},{"key":"10.1016\/j.leukres.2024.107566_bib61","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13133246","article-title":"Germline ERBB2\/HER2 Coding Variants Are Associated with Increased Risk of Myeloproliferative Neoplasms","volume":"13","author":"Braunstein","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.leukres.2024.107566_bib62","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/s41375-021-01319-w","article-title":"Germline ATG2B\/GSKIP-containing 14q32 duplication predisposes to early clonal hematopoiesis leading to myeloid neoplasms","volume":"36","author":"Pegliasco","year":"2022","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2024.107566_bib63","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1182\/blood-2018-99-110366","article-title":"ATG2B\/Gskip in De Novo acute myeloid leukemia (AML): high prevalence of germline predisposition in french west indies and potential role of overexpression in acquired AML","volume":"132","author":"Pegliasco","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2024.107566_bib64","first-page":"492","article-title":"Duplication on chromosome 14q identified in familial predisposition to myeloid malignancies and myeloproliferative neoplasms","volume":"130","author":"Hahn","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2024.107566_bib65","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1038\/s41375-018-0231-9","article-title":"Germline duplication of ATG2B and GSKIP genes is not required for the familial myeloid malignancy syndrome associated with the duplication of chromosome 14q32","volume":"32","author":"Babushok","year":"2018","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2024.107566_bib66","article-title":"Risk factors for clonal hematopoiesis of indeterminate potential and mosaic chromosomal alterations","author":"Jakubek","year":"2022","journal-title":"Transl. Res."},{"key":"10.1016\/j.leukres.2024.107566_bib67","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/s41586-023-05806-1","article-title":"Aberrant activation of TCL1A promotes stem cell expansion in clonal haematopoiesis","volume":"616","author":"Weinstock","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.leukres.2024.107566_bib68","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.3324\/haematol.2009.005918","article-title":"Evidence for a founder effect of the MPL-S505N mutation in eight Italian pedigrees with hereditary thrombocythemia","volume":"94","author":"Liu","year":"2009","journal-title":"Haematologica"},{"key":"10.1016\/j.leukres.2024.107566_bib69","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1182\/blood.V120.21.1764.1764","article-title":"F. Germline MPLW515R mutation in a family with isolated thrombocytosis","volume":"120","author":"Vilaine","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2024.107566_bib70","doi-asserted-by":"crossref","first-page":"11444","DOI":"10.1073\/pnas.0404241101","article-title":"Mpl Baltimore: a thrombopoietin receptor polymorphism associated with thrombocytosis","volume":"101","author":"Moliterno","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.leukres.2024.107566_bib71","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1365-2141.2008.07430.x","article-title":"Familial thrombocytosis caused by the novel germ-line mutation p.Pro106Leu in the MPL gene","volume":"144","author":"El-Harith el","year":"2009","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.leukres.2024.107566_bib72","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1111\/bjh.17624","article-title":"Clinical course of myeloproliferative leukaemia virus oncogene (MPL) mutation-associated familial thrombocytosis: a review of 64 paediatric and adult patients","volume":"194","author":"Al-Harbi","year":"2021","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.leukres.2024.107566_bib73","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.pathol.2022.05.015","article-title":"Novel modes of MPL activation in triple-negative myeloproliferative neoplasms","volume":"55","author":"Samaraweera","year":"2023","journal-title":"Pathology"},{"key":"10.1016\/j.leukres.2024.107566_bib74","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1111\/bjh.17741","article-title":"Hereditary thrombocytosis: the genetic landscape","volume":"194","author":"Han","year":"2021","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.leukres.2024.107566_bib75","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1182\/blood-2009-04-217851","article-title":"Association of hereditary thrombocythemia and distal limb defects with a thrombopoietin gene mutation","volume":"114","author":"Graziano","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2024.107566_bib76","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1056\/NEJMc1200349","article-title":"Germline JAK2 mutation in a family with hereditary thrombocytosis","volume":"366","author":"Mead","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.leukres.2024.107566_bib77","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1182\/blood-2012-12-473777","article-title":"A novel activating, germline JAK2 mutation, JAK2R564Q, causes familial essential thrombocytosis","volume":"123","author":"Etheridge","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2024.107566_bib78","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/ajh.23614","article-title":"A novel germline JAK2 mutation in familial myeloproliferative neoplasms","volume":"89","author":"Rumi","year":"2014","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.leukres.2024.107566_bib79","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1182\/blood-2013-05-504555","article-title":"Germ-line JAK2 mutations in the kinase domain are responsible for hereditary thrombocytosis and are resistant to JAK2 and HSP90 inhibitors","volume":"123","author":"Marty","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2024.107566_bib80","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.3324\/haematol.2016.144063","article-title":"Gene panel sequencing improves the diagnostic work-up of patients with idiopathic erythrocytosis and identifies new mutations","volume":"101","author":"Camps","year":"2016","journal-title":"Haematologica"},{"key":"10.1016\/j.leukres.2024.107566_bib81","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1006\/bcmd.2002.0488","article-title":"Endemic polycythemia in Russia: mutation in the VHL gene","volume":"28","author":"Ang","year":"2002","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.leukres.2024.107566_bib82","doi-asserted-by":"crossref","first-page":"e87","DOI":"10.3324\/haematol.2019.216267","article-title":"Thrombotic risk in congenital erythrocytosis due to up-regulated hypoxia sensing is not associated with elevated hematocrit","volume":"105","author":"Gordeuk","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.leukres.2024.107566_bib83","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1182\/blood-2014-10-604660","article-title":"Complications in children and adolescents with Chuvash polycythemia","volume":"125","author":"Sergueeva","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2024.107566_bib84","doi-asserted-by":"crossref","first-page":"3066","DOI":"10.1182\/blood.V78.11.3066.3066","article-title":"Autosomal dominant erythrocytosis caused by increased sensitivity to erythropoietin","volume":"78","author":"Juvonen","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2024.107566_bib85","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/0140-6736(93)92558-B","article-title":"Familial erythrocytosis genetically linked to erythropoietin receptor gene","volume":"341","author":"de la Chapelle","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.leukres.2024.107566_bib86","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1182\/blood.V86.1.15.bloodjournal86115","article-title":"Primary familial polycythemia: a frameshift mutation in the erythropoietin receptor gene and increased sensitivity of erythroid progenitors to erythropoietin","volume":"86","author":"Sokol","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2024.107566_bib87","doi-asserted-by":"crossref","first-page":"575","DOI":"10.3324\/haematol.2017.176370","article-title":"New pathogenic mechanisms induced by germline erythropoietin receptor mutations in primary erythrocytosis","volume":"103","author":"Pasquier","year":"2018","journal-title":"Haematologica"},{"key":"10.1016\/j.leukres.2024.107566_bib88","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/bjh.12782","article-title":"Polycythaemia-inducing mutations in the erythropoietin receptor (EPOR): mechanism and function as elucidated by epidermal growth factor receptor-EPOR chimeras","volume":"165","author":"Gross","year":"2014","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.leukres.2024.107566_bib89","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1056\/NEJMoa1709064","article-title":"A Gain-of-Function Mutation in EPO in Familial Erythrocytosis","volume":"378","author":"Zmajkovic","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.leukres.2024.107566_bib90","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1182\/blood-2016-02-698951","article-title":"Cooperation of germ line JAK2 mutations E846D and R1063H in hereditary erythrocytosis with megakaryocytic atypia","volume":"128","author":"Kapralova","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2024.107566_bib91","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1111\/bjh.18320","article-title":"Heterozygous, germline JAK2 E846D substitution as the cause of familial erythrocytosis","volume":"198","author":"Tun","year":"2022","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.leukres.2024.107566_bib92","doi-asserted-by":"crossref","first-page":"e101","DOI":"10.3324\/haematol.2013.090175","article-title":"Infrequent occurrence of mutations in the PH domain of LNK in patients with JAK2 mutation-negative 'idiopathic' erythrocytosis","volume":"98","author":"Spolverini","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.leukres.2024.107566_bib93","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1056\/NEJMra1409760","article-title":"Mast Cells, Mastocytosis, and Related Disorders","volume":"373","author":"Theoharides","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.leukres.2024.107566_bib94","doi-asserted-by":"crossref","DOI":"10.1097\/HS9.0000000000000646","article-title":"Updated Diagnostic Criteria and Classification of Mast Cell Disorders: A Consensus Proposal","volume":"5","author":"Valent","year":"2021","journal-title":"Hemasphere"},{"key":"10.1016\/j.leukres.2024.107566_bib95","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1038\/ng.3696","article-title":"Elevated basal serum tryptase identifies a multisystem disorder associated with increased TPSAB1 copy number","volume":"48","author":"Lyons","year":"2016","journal-title":"Nat. Genet."},{"key":"10.1016\/j.leukres.2024.107566_bib96","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s10875-018-0506-y","article-title":"First identification of an inherited TPSAB1 quintuplication in a patient with clonal mast cell disease","volume":"38","author":"Sabato","year":"2018","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.leukres.2024.107566_bib97","doi-asserted-by":"crossref","first-page":"3549","DOI":"10.1016\/j.jaip.2020.05.057","article-title":"Hereditary alpha-tryptasemia: UK prevalence and variability in disease expression","volume":"8","author":"Robey","year":"2020","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"10.1016\/j.leukres.2024.107566_bib98","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.jaci.2020.06.035","article-title":"Heritable risk for severe anaphylaxis associated with increased alpha-tryptase-encoding germline copy number at TPSAB1","volume":"147","author":"Lyons","year":"2021","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.leukres.2024.107566_bib99","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1182\/blood.2020006157","article-title":"Hereditary alpha tryptasemia is a valid genetic biomarker for severe mediator-related symptoms in mastocytosis","volume":"137","author":"Greiner","year":"2021","journal-title":"Blood"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212624001322?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212624001322?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,25]],"date-time":"2024-10-25T17:48:18Z","timestamp":1729878498000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212624001322"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":99,"alternative-id":["S0145212624001322"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2024.107566","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Germline genetic variants that predispose to myeloproliferative neoplasms and hereditary myeloproliferative phenotypes","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2024.107566","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107566"}}